|
1
|
Moon JC, Messroghli DR, Kellman P,
Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich
MG, Neubauer S, et al: Society for Cardiovascular Magnetic
Resonance Imaging; Cardiovascular Magnetic Resonance Working Group
of the European Society of Cardiology: Myocardial T1 mapping and
extracellular volume quantification: A Society for Cardiovascular
Magnetic Resonance (SCMR) and CMR Working Group of the European
Society of Cardiology consensus statement. J Cardiovasc Magn Reson.
15:922013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Malhotra A, Kahlon P, Donoho T and Doyle
IC: Pharmacogenomic considerations in the treatment of the
pediatric cardiomyopathy called Barth syndrome. Recent Pat
Biotechnol. 8:136–143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pankuweit S, Richter A, Ruppert V and
Maisch B: Classification of cardiomyopathies and indication for
endomyocardial biopsy revisited. Herz. 34:55–62. 2009.(In German).
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yoo SJ, Grosse-Wortmann L and Hamilton RM:
Magnetic resonance imaging assessment of arrhythmogenic right
ventricular cardiomyopathy/dysplasia in children. Korean Circ J.
40:357–367. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kipps AK, Ramamoorthy C, Rosenthal DN and
Williams GD: Children with cardiomyopathy: Complications after
noncardiac procedures with general anesthesia. Paediatr Anaesth.
17:775–781. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Colan SD, Lipshultz SE, Lowe AM, Sleeper
LA, Messere J, Cox GF, Lurie PR, Orav EJ and Towbin JA:
Epidemiology and cause-specific outcome of hypertrophic
cardiomyopathy in children: Findings from the Pediatric
Cardiomyopathy Registry. Circulation. 115:773–781. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu Z, Huang M, Jun L and Zhang Y: Review
on Diagnosis and Treatment of cardiomyopathy of Children for 10
Year. J Clin Pediatr. 4:345–348. 2011.
|
|
8
|
Elliott P, Andersson B, Arbustini E,
Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B,
McKenna WJ, et al: Classification of the cardiomyopathies: A
position statement from the european society of cardiology working
group on myocardial and pericardial diseases. Eur Heart J.
29:270–276. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stehlik J, Edwards LB, Kucheryavaya AY,
Benden C, Christie JD, Dipchand AI, Dobbels F, Kirk R, Rahmel AO
and Hertz MI: International Society of Heart and Lung
Transplantation: The Registry of the International Society for
Heart and Lung Transplantation: 29th official adult heart
transplant report - 2012. J Heart Lung Transplant. 31:1052–1064.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alkaladi A, Abdelazim AM and Afifi M:
Antidiabetic activity of zinc oxide and silver nanoparticles on
streptozotocin-induced diabetic rats. Int J Mol Sci. 15:2015–2023.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kishimoto S, Suda K, Yoshimoto H,
Teramachi Y, Nishino H, Koteda Y, Itoh S, Kudo Y, Iemura M and
Matsuishi T: Thirty-year follow-up of carnitine supplementation in
two siblings with hypertrophic cardiomyopathy caused by primary
systemic carnitine deficiency. Int J Cardiol. 159:e14–e15. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takahashi R, Asai T, Murakami H, Murakami
R, Tsuzuki M, Numaguchi Y, Matsui H, Murohara T and Okumura K:
Pressure overload-induced cardiomyopathy in heterozygous carrier
mice of carnitine transporter gene mutation. Hypertension.
50:497–502. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Towbin JA: Cardiomyopathy and heart
transplantation in children. Curr Opin Cardiol. 17:274–279. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sarafoglou K, Tridgell AHC, Bentler K,
Redlinger-Grosse K, Berry SA and Schimmenti LA: Cardiac conduction
improvement in two heterozygotes for primary carnitine deficiency
on L-carnitine supplementation. Clin Genet. 78:191–194. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li FY, El-Hattab AW, Bawle EV, Boles RG,
Schmitt ES, Scaglia F and Wong LJ: Molecular spectrum of SLC22A5
(OCTN2) gene mutations detected in 143 subjects evaluated for
systemic carnitine deficiency. Hum Mutat. 31:E1632–E1651. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wexler RK, Elton T, Pleister A and Feldman
D: Cardiomyopathy: An overview. Am Fam Physician. 79:778–784.
2009.PubMed/NCBI
|
|
17
|
Hershberger RE, Cowan J, Morales A and
Siegfried JD: Progress with genetic cardiomyopathies: Screening,
counseling, and testing in dilated, hypertrophic, and
arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ
Heart Fail. 2:253–261. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Murphy RT, Thaman R, Blanes JG, Ward D,
Sevdalis E, Papra E, Kiotsekoglou A, Tome MT, Pellerin D, McKenna
WJ and Elliott PM: Natural history and familial characteristics of
isolated left ventricular non-compaction. Eur Heart J. 26:187–192.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Escher F, Vetter R, Kühl U, Westermann D,
Schultheiss HP and Tschöpe C: Fractalkine in human inflammatory
cardiomyopathy. Heart. 97:733–739. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Towbin JA, Lowe AM, Colan SD, Sleeper LA,
Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, et al:
Incidence, causes, and outcomes of dilated cardiomyopathy in
children. JAMA. 296:1867–1876. 2006. View Article : Google Scholar : PubMed/NCBI
|
